Association Between Serum Matrix Metalloproteinase‐3 Levels and Cognitive Function in Patients With Rheumatoid Arthritis
International Journal of Rheumatic Diseases · 2026-05 · 29 (5)
DOI: 10.1111/1756-185x.70686 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 08.05.2026. Verfasst von Masahiro Tada und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Osaka City General Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 3, Cognitive Dysfunction, Arthritis, Rheumatoid, Inflammation Mediators. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Introduction
Cognitive impairment is increasingly recognized as a clinically relevant comorbidity in patients with rheumatoid arthritis (RA). Although chronic inflammation has been implicated in cognitive vulnerability, the relationship between RA‐related inflammatory markers and cognitive function has not been fully elucidated.
Methods
In this cross‐sectional study, patients with RA underwent cognitive assessment using the Mini‐Mental State Examination (MMSE). Serum matrix metalloproteinase‐3 (MMP‐3) and erythrocyte sedimentation rate (ESR) were evaluated as inflammatory markers. Multivariable linear regression analyses were performed to examine factors associated with MMSE score, adjusting for age, sex, educational level, and frailty. Sensitivity analyses included additional adjustments for ESR, renal function, and glucocorticoid use. Mild cognitive impairment (MCI), defined as an MMSE score ≤ 27, was examined using logistic regression models.
Results
A total of 130 patients were included, of whom 34 were classified as having MCI. Higher serum MMP‐3 levels were associated with lower MMSE scores after adjustment for demographic factors, educational level, and frailty. This association remained significant after additional adjustment for ESR, whereas ESR itself was not associated with MMSE score in fully adjusted models. Higher MMP‐3 levels were also associated with increased odds of MCI, and this association remained significant in analyses restricted to female patients.
Conclusions
Serum MMP‐3 levels were associated with cognitive function in patients with RA, whereas ESR was not. These findings suggest that RA‐related inflammatory activity reflected by MMP‐3 may be relevant to cognitive vulnerability beyond nonspecific inflammation. Further longitudinal studies are warranted to clarify temporal relationships and clinical implications of these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Osaka City General Hospital, Osaka, Japan.
- Department of Nutrition, Graduate School of Human Life and Ecology, Osaka Metropolitan University, Osaka, Japan.
- Department of General Medicine, Osaka City General Hospital, Osaka, Japan.
ORCID-Profile: Masahiro Tada
Zitieren
APA
Tada, M., Matsumoto, Y., Nakamura, T., Goto, H., & Matsuura, M. (2026). Association Between Serum Matrix Metalloproteinase‐3 Levels and Cognitive Function in Patients With Rheumatoid Arthritis. International Journal of Rheumatic Diseases, 29(5). https://doi.org/10.1111/1756-185x.70686
Vancouver
Tada M, Matsumoto Y, Nakamura T, Goto H, Matsuura M. Association Between Serum Matrix Metalloproteinase‐3 Levels and Cognitive Function in Patients With Rheumatoid Arthritis. International Journal of Rheumatic Diseases. 2026;29(5). doi:10.1111/1756-185x.70686
BibTeX
@article{Tada2026,
author = {Tada, Masahiro and Matsumoto, Yoshinari and Nakamura, Tomoyuki and Goto, Hitoshi and Matsuura, Masanori},
title = {Association Between Serum Matrix Metalloproteinase‐3 Levels and Cognitive Function in Patients With Rheumatoid Arthritis},
journal = {International Journal of Rheumatic Diseases},
year = {2026},
volume = {29},
number = {5},
doi = {10.1111/1756-185x.70686}
}
EUVIMED